CANCER THERAPY INNOVATIONS Trademark
Trademark Overview
On Thursday, March 27, 2003, a trademark application was filed for CANCER THERAPY INNOVATIONS with the United States Patent and Trademark Office. The USPTO has given the CANCER THERAPY INNOVATIONS trademark a serial number of 76501994. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, June 8, 2004. This trademark is owned by CANCER THERAPY INNOVATIONS, INC.. The CANCER THERAPY INNOVATIONS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
SCIENTIFIC RESEARCH SERVICES IN THE FIELD OF ONCOLOGY
General Information
Serial Number | 76501994 |
Word Mark | CANCER THERAPY INNOVATIONS |
Filing Date | Thursday, March 27, 2003 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Tuesday, June 8, 2004 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | SCIENTIFIC RESEARCH SERVICES IN THE FIELD OF ONCOLOGY |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 14, 2003 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | CANCER THERAPY INNOVATIONS, INC. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Toronto, ON M5J 2H7 CA |
Trademark Events
Event Date | Event Description |
Tuesday, June 8, 2004 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, September 24, 2003 | NON-FINAL ACTION MAILED |
Monday, September 22, 2003 | ASSIGNED TO EXAMINER |